A recipient of the 2025 Elite Trial Lawyers Lifetime Achievement Award, Morgan & Morgan's John Yanchunis spoke with the National Law Journal about his storied career, from bringing one of the nation’s ...

A Cambridge-based company developing gene therapies for rare diseases is laying off more than a third of its workforce.

The layoffs followed a March announcement by Health Secretary Robert F. Kennedy Jr., who called for a major department overhaul.

An estimated 53 drugs would not enter the market in the next 30 years if the NIH is hit with a permanent 10% budget cut and the FDA experiences a nine-month drug review delay due to staffing cuts, the ...

Sino Biopharma will acquire LaNova Medicines, which has licensed cancer drugs for Merck and AstraZeneca, for $951 million.

Trump administration officials have defended the mass dismissals, saying they are overdue and necessary to make the department leaner and more efficient. Among the employees laid off are more than 100 ...

According to the company's global financial results for the first quarter, released in May, declines of 19 percent in the ...

Other agencies are moving forward with RIFs and terminations, but official tells federal court some plans have changed.

The investigative unit, which looks into potential safety issues with drugs, vaccines, medical devices, and other products, has had a retention problem for years. Inspectors leave so often that, even ...

Loss of support staff has slowed critical investigations of drug manufacturers. Little relief has materialized.

The number of employees laid off and companies letting people go increased year over year during the first half of 2025.

Policy FDA layoffs could compromise safety of medications made at foreign factories, inspectors say Beyond staff cuts, the departures of some longtime investigators in recent months have left less ...